Tacrolimus, beclomethasone effective treatments for ulcerative proctitis 5-ASA refractory

New data showed similar clinical and endoscopic responses between tacrolimus and beclomethasone suppositories in patients with ulcerative proctitis refractory to 5-aminosalicylic acid, according to a study published in Clinical Gastroenterology and Hepatology.
“There were no significant differences in adverse events rates,” Mitchell R.K.L. Lie, MD, from the department of Gastroenterology and Hepatology at Erasmus MC University Medical Center Rotterdam, in the Netherlands, said. “Tacrolimus and beclomethasone suppositories are therefore each safe and effective treatment

Source link

Related posts

MDROs jeopardize antibiotic prophylaxis for spontaneous bacterial peritonitis in patients with cirrhosis


ERCP and EUS Volumes During Training: How Many Cases Is Enough?


Treg cell tune-up


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World